Related Experiment Videos
Current trends in hormone replacement therapy
1Department of Obstetrics and Gynecology, King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia.
Saudi Medical Journal
|June 19, 2002
Summary
Hormone replacement therapy (HRT) significantly reduces risks of osteoporosis and heart disease in post-menopausal women. HRT improves quality of life and outweighs potential cancer risks.
Area of Science:
- Reproductive Medicine
- Gerontology
- Cardiovascular Health
Background:
- Increasing lifespan leads to more women experiencing long-term menopause consequences.
- Menopause and climacteric significantly impact women's well-being, causing vasomotor, psychological, and sexual symptoms.
- There is an increased risk of osteoporosis and atherosclerosis post-menopause.
Purpose of the Study:
- To evaluate the long-term benefits of post-menopausal hormone replacement therapy (HRT).
- To assess HRT's role in preventing osteoporosis and reducing cardiovascular risks.
- To review available estrogen preparations and their administration routes.
Main Methods:
- Review of existing evidence on hormone replacement therapy efficacy and safety.
- Analysis of data comparing coronary artery disease rates in HRT users versus non-users.
- Examination of fracture risk reduction associated with estrogen replacement therapy.
Main Results:
- Post-menopausal women on HRT have approximately half the rate of coronary artery disease.
- Estrogen replacement for 5 years reduces overall fracture risk by 50%, aiding osteoporosis management.
- HRT demonstrably improves quality of life and reduces morbidity and mortality.
Conclusions:
- HRT effectively reverses metabolic and pathological changes induced by menopause.
- The benefits of HRT in improving health outcomes and quality of life are substantial.
- Evidence suggests HRT benefits outweigh potential risks like venous thromboembolism or certain cancers.